Safety and feasibility of a new psychotherapeutic intervention for secured acute psychiatric wards – MCT-A

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00020551

Enrollment

Registered

2020-02-04

Start date

2020-02-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F20-F29 F30-F39 F60-F69 F10-F19 F40-F48 F50-F59 F90-F98 F00-F09

Interventions

Group 1: Participation in the group intervention MCT-A over 4 weeks (7 modules in total, 2 per week each)

participation in pre-, interim and post-assessment

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Presence on a secured, closed acute psychiatric ward; diagnosis of a severe psychiatric illness (F diagnosis according to ICD-10)

Exclusion criteria

Exclusion criteria: Inability to give informed consent / no consent from the legal guardian, lack of German language skills, mental retardation, and dementia

Design outcomes

Primary

Measure	Time frame
Overall satisfaction with and subjective utility of the intervention (self-generated questionnaire); measured after 2 and after 4 weeks, i.e. when participants have participated in up to 4 and up to 7 modules respectively.	—

Secondary

Measure	Time frame
- Abbreviated version of the Questionnaire about Side Effects Psychosis and Internet (QueSPI; Rüegg, Moritz, Berger, Lüdtke & Westermann, 2018): Side effects of the intervention; reported after 2 and 4 weeks - UE-ATR checklist: Number of adverse events associated with the intervention; continuously documented by members of the research team during the intervention period - Subscale Hope of the questionnaire on therapy motivation-23: Hope regarding therapy; before, during (after 2 weeks) and after the intervention (after 4 weeks) - Brief Symptom Inventory: Subjective symptom severity; before, during and after the intervention - Self-Stigma of Mental Illness Scale - Short Form: self-stigmatization; before, during and after the intervention - Brief Psychiatric Rating Scale, Global Assessment of Functioning, Clinical Global Impression: externally assessed symptom severity; before, during and after the intervention - Abbreviated version of the Bochum Change Questionnaire 2000: changes compared to before the start of therapy; after the intervention	—

Measure

Time frame

- Abbreviated version of the Questionnaire about Side Effects Psychosis and Internet (QueSPI; Rüegg, Moritz, Berger, Lüdtke & Westermann, 2018): Side effects of the intervention; reported after 2 and 4 weeks - UE-ATR checklist: Number of adverse events associated with the intervention; continuously documented by members of the research team during the intervention period - Subscale Hope of the questionnaire on therapy motivation-23: Hope regarding therapy; before, during (after 2 weeks) and after the intervention (after 4 weeks) - Brief Symptom Inventory: Subjective symptom severity; before, during and after the intervention - Self-Stigma of Mental Illness Scale - Short Form: self-stigmatization; before, during and after the intervention - Brief Psychiatric Rating Scale, Global Assessment of Functioning, Clinical Global Impression: externally assessed symptom severity; before, during and after the intervention - Abbreviated version of the Bochum Change Questionnaire 2000: changes compared to before the start of therapy; after the intervention

—

Countries

Germany

Contacts

Public ContactSteffen Moritz

Universitätsklinikum Hamburg-EppendorfKlinik und Poliklinik für Psychiatrie und PsychotherapieArbeitsgruppe Klinische Neuropsychologie

moritz@uke.de+49 40 7410 56565

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026